scholarly article | Q13442814 |
P819 | ADS bibcode | 1993PNAS...90.6280R |
P356 | DOI | 10.1073/PNAS.90.13.6280 |
P932 | PMC publication ID | 46912 |
P698 | PubMed publication ID | 8327510 |
P5875 | ResearchGate publication ID | 14870810 |
P50 | author | Michael Reiss | Q56547220 |
P2093 | author name string | J M Cowan | |
Z L Zhou | |||
T Muñoz-Antonia | |||
P C Wilkins | |||
V F Vellucci | |||
P2860 | cites work | TGF beta signals through a heteromeric protein kinase receptor complex | Q24337608 |
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
Identification of a chromosome 18q gene that is altered in colorectal cancers | Q28274172 | ||
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53 | Q29547773 | ||
The transforming growth factor-beta family | Q29615948 | ||
Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer | Q34538564 | ||
mRNA phenotyping by enzymatic amplification of randomly primed cDNA. | Q36073108 | ||
Transforming growth factor-beta: possible roles in carcinogenesis | Q36465897 | ||
Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. | Q36886337 | ||
Mutant p53 can induce tumorigenic conversion of human bronchial epithelial cells and reduce their responsiveness to a negative growth factor, transforming growth factor beta 1 | Q36920336 | ||
Escape from transforming growth factor beta control and oncogene cooperation in skin tumor development | Q37611617 | ||
Analysis of genes and chromosomes by nonisotopic in situ hybridization | Q37740240 | ||
Chapter 18 Induction of Mammalian Somatic Cell Hybridization by Polyethylene Glycol | Q39152538 | ||
Chromosome losses in tumorigenic revertants of EJ/ras-expressing somatic cell hybrids | Q41083849 | ||
Cytogenetic evidence of the multistep origin of head and neck squamous cell carcinomas | Q41117144 | ||
Mutant p53 tumor suppressor gene causes resistance to transforming growth factor beta 1 in murine keratinocytes | Q41573537 | ||
Expression cloning of the TGF-β type II receptor, a functional transmembrane serine/threonine kinase | Q41639273 | ||
Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias | Q41643691 | ||
Induction and autocrine receptor binding of transforming growth factor-beta 2 during terminal differentiation of primary mouse keratinocytes | Q42479606 | ||
Detection of both mutant and wild-type p53 protein in normal skin fibroblasts and demonstration of a shared 'second hit' on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndrome | Q42602478 | ||
Reversible inhibition of normal human prokeratinocyte proliferation by type beta transforming growth factor-growth inhibitor in serum-free medium | Q45345222 | ||
A new human cell line (FaDu) from a hypopharyngeal carcinoma. | Q52829962 | ||
High frequency of resistance of human squamous carcinoma cells to the anti-proliferative action of transforming growth factor beta. | Q53510902 | ||
Continuous cell lines with altered growth and differentiation properties originate after transfection of human keratinocytes with human papillomavirus type 16 DNA. | Q54378341 | ||
Drug-resistant mutants: selection and dominance analysis. | Q54415860 | ||
bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship | Q57338704 | ||
Status of the p53 tumor suppressor gene in human squamous carcinoma cell lines | Q67991606 | ||
Regulation of growth and differentiation of human keratinocytes by type beta transforming growth factor and epidermal growth factor | Q69009790 | ||
Growth modulation of mouse keratinocytes by transforming growth factors | Q69019850 | ||
Reinitiation of DNA synthesis in quiescent mouse keratinocytes; regulation by polypeptide hormones, cholera toxin, dexamethasone, and retinoic acid | Q69032172 | ||
Modulation of the mitogenic response of an epidermal growth factor-dependent keratinocyte cell line by dexamethasone, insulin, and transforming growth factor-beta | Q69036524 | ||
Phenotype of low proliferative potential is dominant in hybrids of normal human fibroblasts | Q70572057 | ||
P433 | issue | 13 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 5 | |
P304 | page(s) | 6280-6284 | |
P577 | publication date | 1993-07-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | Resistance of human squamous carcinoma cells to transforming growth factor beta 1 is a recessive trait | |
P478 | volume | 90 |
Q33888325 | Angiogenesis in the development of head and neck cancer and its inhibition by chemopreventive agents |
Q37227206 | Attenuated transforming growth factor beta signaling promotes nuclear factor-kappaB activation in head and neck cancer. |
Q73969923 | Combined copy status of 18q21 genes in colorectal cancer shows frequent retention of SMAD7 |
Q54127845 | Extracellular matrix-associated transforming growth factor-beta: role in cancer cell growth and invasion. |
Q33957851 | Interferon regulatory factor 2 represses the Epstein-Barr virus BamHI Q latency promoter in type III latency |
Q33834888 | Interferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1. |
Q24681272 | Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II |
Q35782377 | Retinoic acid induces cells cultured from oral squamous cell carcinomas to become anti-angiogenic. |
Q27824786 | SMAD4 is a predictive marker for 5-fluorouracil-based chemotherapy in patients with colorectal cancer |
Q42519294 | TGF beta promotes the basal phenotype of epidermal keratinocytes: transcriptional induction of K#5 and K#14 keratin genes |
Q41442972 | Transforming growth factor-beta and prostate cancer. |
Search more.